Treating the Fire

Medications for Parkinson's primarily address symptoms rather than underlying causes, akin to treating smoke without extinguishing the fire. Recent research shows that a diabetes drug, a GLP1 agonist, not only stabilizes patients but may even improve their functionality, marking a significant shift in treatment strategies. However, potential side effects, such as gastrointestinal issues, must be weighed against the benefits, highlighting the importance of informed decision-making for patients and caregivers.